Federal Circuit dismisses Phigenix patent appeal in ImmunoGen case

10-01-2017

Federal Circuit dismisses Phigenix patent appeal in ImmunoGen case

tonefotografia / shutterstock.com

Pharmaceutical research company Phigenix lost an appeal at the US Court of Appeals for the Federal Circuit yesterday, after the court found that the company lacked standing in a patent case against ImmunoGen.


Phigenix, Immunogen, patent, inter partes review, US Court of Appeals for the Federal Circuit, injury

LSIPR